FORTE Clinical Study

RTI Surgical Enrolls First Patient in FORTE Clinical Study of Fortilink® Interbody Fusion Device with TETRAfuse® 3D Technology

DEERFIELD, Ill., March 20, 2019 (GLOBE NEWSWIRE) — RTI Surgical Holdings, Inc. (NASDAQ: RTIX), a global surgical implant company, today announced…